- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/71 - ReceptorsCell surface antigensCell surface determinants for growth factorsReceptorsCell surface antigensCell surface determinants for growth regulators
Patent holdings for IPC class C07K 14/71
Total number of patents in this class: 2094
10-year publication summary
|
122
|
147
|
164
|
177
|
159
|
233
|
250
|
199
|
156
|
52
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 359 |
139 |
| Regeneron Pharmaceuticals, Inc. | 4140 |
132 |
| Amgen Inc. | 3985 |
34 |
| Immatics Biotechnologies GmbH | 1146 |
31 |
| The Regents of the University of California | 19681 |
29 |
| Board of Regents, The University of Texas System | 5689 |
24 |
| Keros Therapeutics, Inc. | 60 |
22 |
| Genentech, Inc. | 3898 |
20 |
| The Board of Trustees of the Leland Stanford Junior University | 6296 |
20 |
| City of Hope | 966 |
20 |
| The Trustees of the University of Pennsylvania | 4282 |
18 |
| Genzyme Corporation | 1227 |
18 |
| Immunitybio, Inc. | 347 |
17 |
| Merck Patent GmbH | 5825 |
16 |
| The Johns Hopkins University | 5575 |
16 |
| Biocon Limited | 221 |
16 |
| Precigen Inc | 113 |
16 |
| Novartis AG | 11042 |
15 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3356 |
15 |
| Janssen Biotech, Inc. | 1490 |
13 |
| Other owners | 1463 |